 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

This is a signal that SCPH's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options...

scPharmaceuticals (SCPH, $7.12) Stochastic Oscillator left the oversold zone on September 26, 2023

scPharmaceuticals (SCPH, $7.04) Stochastic Oscillator left the oversold zone on September 22, 2023

This is a Bearish indicator signaling SCPH's price could decline from here. Traders may explore shorting the stock or put options...

scPharmaceuticals (SCPH, $7.14) Moving Average Convergence Divergence (MACD) Histogram turned negative on September 13, 2023

This is a Bullish indicator signaling SCPH's price could rise from here. Traders may explore going long the stock or buying call options...

scPharmaceuticals (SCPH, $7.59) Moving Average Convergence Divergence (MACD) Histogram turned positive on September 11, 2023

scPharmaceuticals (SCPH, $7.59) Stochastic Oscillator left the oversold zone on September 11, 2023

Craig Hallum began coverage on shares of scPharmaceuticals (NASDAQ:SCPH  Free Report) in a research note issued to investors on Thursday, MarketBeat.com reports. The firm issued a buy rating...

scPharmaceuticals (NASDAQ:SCPH) Receives New Coverage from Analysts at Craig Hallum

scPharmaceuticals Inc. (NASDAQ:SCPH  Get Free Report) has received an average recommendation of Buy from the six brokerages that are covering the firm, Marketbeat reports. Six...

Brokerages Set scPharmaceuticals Inc. (NASDAQ:SCPH) PT at $19.17

Equities research analysts at Craig Hallum started coverage on shares of scPharmaceuticals (NASDAQ:SCPH  Get Free Report) in a research report issued on Thursday, MarketBeat Ratings reports...

scPharmaceuticals (NASDAQ:SCPH) Now Covered by Craig Hallum

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

scPharmaceuticals initiated with a Buy at Craig-Hallum

scPharmaceuticals (SCPH, $7) Moving Average Convergence Divergence (MACD) Histogram turned negative on September 6, 2023

scPharmaceuticals, Inc. engages in the development of transformative pharmaceutical products for subcutaneous delivery. Its products include FUROSCIX, a furosemide injection which is used as parenteral diuretic in treating heart failure and scCeftriaxone, used as parenteral antibiotic outside the hospital setting. The company was founded by Pieter Muntendam and Bertram Pitt in February 2013 and is headquartered in Burlington, MA.

Watchers	1,414
52-Wk Low	$3.68
52-Wk High	$12.75

Market Cap	$252.43M
Volume (M)	123,172.00
52-Wk High	$12.75
52-Wk Low	$3.68

SCPH scPharmaceuticals Inc

About

Feed

News

Sentiment

Earnings

Fundamentals